Cart
sales@molnova.com
Lodoxamide ethyl
CAS No. 53882-13-6
Lodoxamide ethyl( —— )
Catalog No. M36189 CAS No. 53882-13-6
lodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 120 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 334 | In Stock |
|
| 50MG | 435 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLodoxamide ethyl
-
NoteResearch use only, not for human use.
-
Brief Descriptionlodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.
-
Descriptionlodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53882-13-6
-
Formula Weight367.74
-
Molecular FormulaC15H14ClN3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(C(OCC)=O)=O)C1=C(Cl)C(NC(C(OCC)=O)=O)=CC(C#N)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-04937319
PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
-
Lauryl maltose neope...
Lauryl maltose neopentyl glycol (LMNG) is a detergent that solubilizes and stabilizes membrane proteins by extracting intact proteins from membranes, thereby enhancing the stability of entities such as G protein-coupled receptors and respiratory system complexes.
-
cjoc42
cjoc42 is an inhibitor of gankyrin, an ankyrin-repeat oncoprotein whose overexpression has been implicated in the development of many cancer types.
